Spinnaker ETF Series (KOOL) Dividend News Alerts
KOOL Stock Quote and Dividend Data
KOOL Dividend History Detail
KOOL Projected 10 Year Dividend Yield
KOOL Competitors News
Apr 05,2024 - KOOL STOCK PRICE 52 WEEK LOW: Spinnaker ETF Series on 04-05-2024 hit a 52 week low of $9.91 |
KOOL) on 10-16-2019 decreased close price > 10% from $6.13 to $4.92 | Oct 16,2019 - CLOSE PRICE DECREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 09-24-2019 increased close price > 10% from $5.33 to $6.40 | Sep 24,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 09-12-2019 increased close price > 10% from $3.79 to $4.18 | Sep 12,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 09-10-2019 increased close price > 10% from $3.51 to $4.10 | Sep 10,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-30-2019 increased close price > 10% from $3.05 to $3.38 | Aug 30,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-14-2019 increased close price > 10% from $2.72 to $3.00 | Aug 14,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 07-06-2019 increased close price > 10% from $2.95 to $3.35 | Jul 06,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 06-19-2019 increased close price > 10% from $2.79 to $3.10 | Jun 19,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 06-07-2019 increased close price > 10% from $2.93 to $3.38 | Jun 07,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 06-06-2019 increased close price > 10% from $0.26 to $2.93 | Jun 06,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 03-14-2019 decreased close price > 10% from $0.35 to $0.31 | Mar 14,2019 - CLOSE PRICE DECREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 02-20-2019 increased close price > 10% from $0.35 to $0.39 | Feb 20,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 01-05-2019 increased close price > 10% from $0.27 to $0.31 | Jan 05,2019 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 12-29-2018 increased close price > 10% from $0.24 to $0.28 | Dec 29,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 11-21-2018 decreased close price > 10% from $0.46 to $0.38 | Nov 21,2018 - CLOSE PRICE DECREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 11-20-2018 increased close price > 10% from $0.30 to $0.46 | Nov 20,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 10-31-2018 decreased close price > 10% from $0.32 to $0.28 | Oct 31,2018 - CLOSE PRICE DECREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 10-04-2018 increased close price > 10% from $0.38 to $0.44 | Oct 04,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 10-03-2018 increased close price > 10% from $0.34 to $0.38 | Oct 03,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 09-05-2018 increased close price > 10% from $0.44 to $0.49 | Sep 05,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-30-2018 increased close price > 10% from $0.37 to $0.45 | Aug 30,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-29-2018 increased close price > 10% from $0.29 to $0.37 | Aug 29,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-25-2018 increased close price > 3% from $0.28 to $0.30 | Aug 25,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-23-2018 increased close price > 3% from $0.27 to $0.28 | Aug 23,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-22-2018 increased close price > 3% from $0.25 to $0.27 | Aug 22,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-21-2018 decreased close price > 3% from $0.28 to $0.25 | Aug 21,2018 - CLOSE PRICE DECREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-15-2018 decreased close price from $0.340 to $0.285 | Aug 15,2018 - CLOSE PRICE DECREASE: Cesca Therapeutics Inc (NASDAQ:
KOOL) on 08-11-2018 increased close price from $0.320 to $0.336 | Aug 11,2018 - CLOSE PRICE INCREASE: Cesca Therapeutics Inc (NASDAQ: